Linezolid Infusion

Linezolid Infusion

Linezolid Infusion is an oxazolidinone-class antibacterial medicine used for the treatment of serious infections caused by susceptible Gram-positive bacteria. It is particularly useful against certain resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and susceptible vancomycin-resistant Enterococcus (VRE) strains. Linezolid Infusion is administered intravenously under the supervision of a qualified healthcare professional.

Wellona Pharma is a trusted pharmaceutical exporter from India, supplying Linezolid Infusion sourced from qualified pharmaceutical manufacturers for international markets with a focus on quality, reliable supply, regulatory documentation, and export-oriented packaging.

Uses

• Treatment of hospital-acquired pneumonia
• Management of community-acquired pneumonia caused by susceptible bacteria
• Treatment of complicated skin and soft tissue infections
• Management of certain MRSA infections
• Treatment of susceptible VRE infections
• Used for serious Gram-positive bacterial infections when clinically appropriate

Advantages

• Effective against several resistant Gram-positive bacteria
• Suitable for intravenous administration in hospitalized patients
• Useful when oral administration is not appropriate
• Good penetration into various body tissues
• Can support IV-to-oral sequential therapy when clinically appropriate
• Important treatment option for selected multidrug-resistant bacterial infections

Possible Side Effects

• Headache
• Nausea or vomiting
• Diarrhoea
• Dizziness
• Changes in blood cell counts, including thrombocytopenia
• Increased liver enzyme levels
• Peripheral or optic neuropathy with prolonged treatment
• Serotonin syndrome may occur with certain interacting medicines

Manufacturer, Exporter & Supplier

Wellona Pharma is a trusted Linezolid Infusion exporter and supplier from India, working with qualified pharmaceutical manufacturers to cater to pharmaceutical importers, distributors, wholesalers, hospitals, government tenders, and healthcare markets worldwide.